Keyphrases
Hearing Impairment
100%
Cancer Patients
100%
Testicular Cancer
100%
Cisplatin-based Chemotherapy
100%
Clinical Data
50%
Genetic Data
33%
ROC-AUC
33%
High Risk
16%
Clinical Practice
16%
Quality of Life
16%
Genome-wide Association Study
16%
Logistic Regression
16%
Early Prevention
16%
Early Detection
16%
False Discovery Rate
16%
Prediction Model
16%
Ototoxicity
16%
Chemotherapy-induced
16%
Long-term Adverse Effects
16%
Superoxide Dismutase 2 (SOD2)
16%
Biological Mechanisms
16%
Receiver Operating Characteristic
16%
Impact on Life
16%
Model Combining
16%
Chemotherapy Side Effects
16%
AUC Curve
16%
Machine Learning Models
16%
Cisplatin-induced Hearing Loss
16%
Loss Development
16%
Omission Rate
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hearing Impairment
100%
Chemotherapy
100%
Testis Cancer
100%
Cisplatin
100%
Side Effect
14%
Ototoxicity
14%